Ecofibre Limited (ASX:EOF)
Australia · Delayed Price · Currency is AUD 0.0200
0.00 (0.00%)
May 1, 2025, 10:12 AM AEST
Ecofibre Company Description
Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.
The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments.
It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer textiles, and hemp related food products.
Further, it is involved in patient-centered cannabinoid-based drug activities. Ecofibre Limited was incorporated in 2009 and is based in Sydney, Australia.
Ecofibre Limited
| Country | Australia |
| Founded | 2009 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Ulrich Tombuelt |
Contact Details
Address: 680 George Street Sydney, 2000 Australia | |
| Phone | 61 7 3265 7630 |
| Website | ecofibre.com |
Stock Details
| Ticker Symbol | EOF |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000040057 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Simon J. Allen B.Sc., M.B.A. | Chief Executive Officer of EOF Bio LLC |
| Ulrich Tombuelt | Chief Executive Officer, MD and Director |
| John Foley | Advisor |
| Amy Elizabeth Donley | Chief Financial Officer |
| Robin Sheldon | General Counsel and Joint Company Secretary |
| Kate Douglass | Group Controller, IT and Joint Company Secretary |
| Alex Nance | President of Ananda Health |